Cataracts affect RNFL and OCT output

Article

The presence of cataracts could influence optical coherence tomography (OCT) signal strength (SS) and peripapillary retinal nerve fibre layer (RNFL) thickness measurements

The presence of cataracts could influence optical coherence tomography (OCT) signal strength (SS) and peripapillary retinal nerve fibre layer (RNFL) thickness measurements, according to a study published in the Journal of Glaucoma.

Dr Jean Mwanza

et al.

, Basom Palmer Eye Institute, University of Miami, Leonard Miller School of Medicine, Miami, Florida, USA, studied 45 cataract patients, 23 of which had glaucoma.

Cataracts were graded with the Lens Opacities Classification System III. Stratus OCT scans were used to measure peripapillary RNFL before and after cataract surgery.

The results revealed a significant postoperative difference in RNFL thickness in patients with a lower preoperative RNFL thickness and SS. The findings also demonstrated no significant difference in RNFL thickness change between cataract patients and patients with both glaucoma and cataract.

The investigation suggests that peripapillary RNFL measurements, especially if SS is weaker, should be interpreted with care in glaucomatous eyes, as cataracts could affect them.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.